References
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1789–1858. doi:https://doi.org/10.1016/S0140-6736(18)32279-7.
- Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3 Pt 2):S1–S53. doi:https://doi.org/10.1164/ajrccm.157.3.157315.
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:https://doi.org/10.1183/09031936.00202013.
- LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282(24):2340–2346. doi:https://doi.org/10.1001/jama.282.24.2340.
- Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, Tershakovec AM, Blazing MA, Braunwald E. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation. 2015;132(13):1224–1233. doi:https://doi.org/10.1161/CIRCULATIONAHA.115.018381.
- Liang L, Hur J, Kang JY, Rhee CK, Kim YK, Lee SY. Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model. Korean J Intern Med. 2018;33(6):1210–1223. doi:https://doi.org/10.3904/kjim.2017.207.
- Wu S, Yang R, Wang G. Anti-asthmatic effect of pitavastatin through aerosol inhalation is associated with CD4+ CD25+ Foxp3+ T cells in an asthma mouse model. Sci Rep. 2017;7(1):6084 doi:https://doi.org/10.1038/s41598-017-06476-6.
- Si XB, Zhang S, Huo L, Dai W, Wang H. Statin therapy does not improve lung function in asthma: a meta-analysis of randomized controlled trials. J Int Med Res. 2013;41(2):276–283. doi:https://doi.org/10.1177/0300060513477005.
- Wardzyńska A, Kubsik B, Kowalski ML. Comorbidities in elderly patients with asthma: Association with control of the disease and concomitant treatment. Geriatr Gerontol Int. 2015;15(7):902–909. doi:https://doi.org/10.1111/ggi.12367.
- Naing C, Ni H. Statins for asthma. Cochrane Database Syst Rev. 2020;7:CD013268. doi:https://doi.org/10.1002/14651858.CD013268.pub2.
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–W94. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00136.
- Kuno T, Takagi H, Ando T, Sugiyama T, Miyashita S, Valentin N, Shimada YJ, Kodaira M, Numasawa Y, Briasoulis A, et al. Oral anticoagulation for patients with atrial fibrillation on long-term hemodialysis. J Am Coll Cardiol. 2020;75(3):273–285. doi:https://doi.org/10.1016/j.jacc.2019.10.059.
- Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe N, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019; 366:14898.
- Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, Jang B-H, Son H-J. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408–414. doi:https://doi.org/10.1016/j.jclinepi.2012.09.016.
- Bonini M, Di Paolo M, Bagnasco D, Baiardini I, Braido F, Caminati M, Carpagnano E, Contoli M, Corsico A, Del Giacco S, et al. Minimal clinically important difference for asthma endpoints: an expert consensus report. Eur Respir Rev. 2020;29(156):190137. doi:https://doi.org/10.1183/16000617.0137-2019.
- Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45(7):769–773. doi:https://doi.org/10.1016/0895-4356(92)90054-Q.
- Moini A, Azimi G, Farivar A. Evaluation of atorvastatin for the treatment of patients with asthma: a double-blind randomized clinical trial. Allergy Asthma Immunol Res. 2012;4(5):290–294. doi:https://doi.org/10.4168/aair.2012.4.5.290.
- Sun S, Han W, Hao W. Clinical studies of simvastatin in treatment of adult-onset obesity with asthma. Biomedical Research. 2017; 28:6514–6517.
- Zeki AA, Oldham J, Wilson M, Fortenko O, Goyal V, Last M, Last A, Patel A, Last JA, Kenyon NJ, et al. Statin use and asthma control in patients with severe asthma. BMJ Open. 2013;3(8):e003314. doi:https://doi.org/10.1136/bmjopen-2013-003314.
- Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax. 2010;65(10):891–896. doi:https://doi.org/10.1136/thx.2010.138990.
- Badar VA, Navale S, Deshmukh S, Munje R, Badar A. The effect of atorvastatin on lung function and sputum cell count in chronic asthma patients. Int J Pharmacol Res. 2014; 4:194–198.
- Braganza G, Chaudhuri R, McSharry C, Weir CJ, Donnelly I, Jolly L, Lafferty J, Lloyd SM, Spears M, Mair F, et al. Effects of short-term treatment with atorvastatin in smokers with asthma-a randomized controlled trial. BMC Pulm Med. 2011; 11:16 doi:https://doi.org/10.1186/1471-2466-11-16.
- Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax. 2008;63(12):1070–1075. doi:https://doi.org/10.1136/thx.2008.100198.
- Fahimi F, Salamzadeh J, Jammati H, Sohrabi S, Fakharian A, Mohammadtaheri Z. Do statins improve lung function in asthmatic patients? A randomized and double-blind trial. Iran J Pharm Sci. 2009; 5:13–20.
- Lokhandwala T, West-Strum D, Banahan BF, Bentley JP, Yang Y. Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis. BMJ Open. 2012;2(3):e001279. doi:https://doi.org/10.1136/bmjopen-2012-001279.
- Tse SM, Li L, Butler MG, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Rusinak D, Weiss ST, et al. Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med. 2013;188(9):1076–1082. doi:https://doi.org/10.1164/rccm.201306-1017OC.
- Tse SM, Charland SL, Stanek E, Herrera V, Goldfarb S, Litonjua AA, Weiss ST, Wu AC. Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits. Curr Med Res Opin. 2014;30(4):685–693. doi:https://doi.org/10.1185/03007995.2013.865599.
- Wang JY, Yao TC, Tsai YT, Wu AC, Tsai HJ. Increased dose and duration of statin use is associated with decreased asthma-related emergency department visits and hospitalizations. J Allergy Clin Immunol Pract. 2018;6(5):1588–1595.e1. doi:https://doi.org/10.1016/j.jaip.2017.12.017.
- Huang C-C, Chan W-L, Chen Y-C, Chen T-J, Chou K-T, Lin S-J, Chen J-W, Leu H-B. Statin use in patients with asthma: a nationwide population-based study. Eur J Clin Invest. 2011;41(5):507–512. doi:https://doi.org/10.1111/j.1365-2362.2010.02434.x.
- Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol. 2007;119(2):328–335. doi:https://doi.org/10.1016/j.jaci.2006.10.014.
- Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol. 2010;126(4):754–762.e1. doi:https://doi.org/10.1016/j.jaci.2010.08.005.
- Mohammad MM, Fahimi F, Fakharian A, Gamishan MK, Sistanizad M, Fayazi N. Methacoline challenge test as an evaluator of response to statins in bronchial hyperresponsiveness. Iran J Pharm Res. 2012; 11:969–977.
- Thomson NC, Charron CE, Chaudhuri R, Spears M, Ito K, McSharry C. Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma. Pulm Pharmacol Ther. 2015;31:1–8. doi:https://doi.org/10.1016/j.pupt.2015.01.001.
- Ostroukhova M, Kouides RW, Friedman E. The effect of statin therapy on allergic patients with asthma. Ann Allergy Asthma Immunol. 2009;103(6):463–468. doi:https://doi.org/10.1016/S1081-1206(10)60261-X.
- Naidoo D, Wu AC, Brilliant MH, Denny J, Ingram C, Kitchner TE, Linneman JG, McGeachie MJ, Roden DM, Shaffer CM, et al. A polymorphism in HLA-G modifies statin benefit in asthma. Pharmacogenomics J. 2015;15(3):272–277. doi:https://doi.org/10.1038/tpj.2014.55.
- Afshar M, Wu D, Arvizu RD, Aguilar FG, Kalhan Md R, Davis SM, Kaplan R, Klein Md OL, Mende EP, Pattany MS, et al. Association of serum lipids and obstructive lung disease in Hispanic/Latino adults of diverse backgrounds. J Pulm Respir Med. 2017;07(04):419. doi:https://doi.org/10.4172/2161-105X.1000419.
- So JY, Dhungana S, Beros JJ, Criner GJ. Statins in the treatment of COPD and asthma-where do we stand?Curr Opin Pharmacol. 2018; 40:26–33. doi:https://doi.org/10.1016/j.coph.2018.01.001.
- Gruenbacher G, Gander H, Rahm A, Dobler G, Drasche A, Troppmair J, et al. The human G protein-coupled ATP receptor P2Y11 is associated with IL-10 driven macrophage differentiation. Front Immunol. 2019;10:1870.
- Bekkering S, Arts RJW, Novakovic B, Kourtzelis I, van der Heijden CDCC, Li Y, Popa CD, Ter Horst R, van Tuijl J, Netea-Maier RT, et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell. 2018;172(1-2):135–146.e9. doi:https://doi.org/10.1016/j.cell.2017.11.025.
- Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651–659. doi:https://doi.org/10.1016/S0140-6736(12)60988-X.